Accepted at 9:14 p.m. Oct, 31, 2023 by Alex
Author: shmuelsash
Related Note: 1509220643527
Rationale for change

Source: https://next.amboss.com/us/article/4m03fg#Lfcb7019dd8836b30200c20021f26f746

Text Text
Extra
Empty field
Lecture Notes
Empty field
Missed Questions
Empty field
Pathoma
Empty field
Boards and Beyond
Empty field
First Aid
Sketchy 2
Empty field
Sketchy Extra
Empty field
Picmonic
Empty field
Pixorize
Empty field
Physeo
Empty field
OME

Additional Resources
Empty field
One by one
Empty field
!AK_UpdateTags::Step1decks::Lolnotacop::Drugs #AK_Step2_v12::#AMBOSS::QK0uTS #AK_Step2_v12::#B&B::15_Renal_and_Genitourinary::05_Other::07_Urinary_Tract_Malignancy #AK_Original_Decks::Step_1::Lolnotacop::Drugs #AK_Step1_v12::#FirstAid::10_Hematology_and_Oncology::05_Pharm::13_Alkylating_agents::*Cyclophosphamide #AK_Step1_v12::#Bootcamp::Pathology::02_Cellular_Injury_&_Neoplasia::11_Cell_Cycle_Independent_Drug_Targets #AK_Step1_v12::#Bootcamp::Hematology_and_Oncology::08_Principles_of_Oncology_and_Therapeutics::11_Cell_Cycle_Independent_Drug_Targets #AK_Step2_v12::#UWorld::COMLEX::28976 #AK_Step1_v12::#SketchyPharm::08_Antineoplastics::02_DNA_&_Cellular_Division::01_Alkylating_Agents #AK_Step1_v12::#OME_banner #AK_Step2_v12::#UWorld::Step::3169